🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a pharmacodynamic bioequivalence bronchoprovocation study using sin...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-15
Trial ID
NCT06618105
Primary Objective: To evaluate the efficacy of dupilumab (SAR231893 / REGN...
Status
Completed
Location
Investigational Site Number 840047
Start Date
2015-04-27
Trial ID
NCT02414854
The study will compare salbutamol reversibility of methacholine induced bro...
Status
Completed
Location
Asthma Research Lab University of Saskatchewan Room 346 Ellis Hall
Start Date
2024-01-12
Trial ID
NCT05977699
Treatments Being Tested
This is a randomised, placebo-controlled, double-blinded, multi-centre, 2-p...
Status
Terminated
Location
Research Site
Start Date
2021-03-12
Trial ID
NCT04643158
Primary objective: The primary objective of the study was to compare the e...
Status
Completed
Location
Chiesi Site No 103
Start Date
2009-03-20
Trial ID
NCT00861926
Treatments Being Tested
This purpose of this study is to determine the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00562159
The purpose of this study is to investigate the efficacy of inhaled cicleso...
Status
Completed
Location
Altana Pharma/Nycomed
Start Date
2006-09
Trial ID
NCT00384189
Treatments Being Tested
The primary purpose of this study is to evaluate lung function and health r...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-25
Trial ID
NCT03478696
The ability for patients with COPD to exercise is limited due to the deteri...
Status
Completed
Location
Spartanburg Medical Research, 485 Simuel Road
Start Date
2010-06
Trial ID
NCT01154127
This is a two-part study conducted at multiple centers, of navarixin (SCH 5...
Status
Terminated
Location
Multiple Locations
Start Date
2006-12-01
Trial ID
NCT00441701
Treatments Being Tested